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Abstract
The production of artificial anti-CB1 antibodies in nanoparticle format is described using the solid-phase imprinting approach. 
Instead of whole protein imprinting, a linear C-terminus sequence of the receptor comprising 15 amino acids (458-KVT-
MSVSTDTSAEAL-472) has been used as template, in accordance with the epitope imprinting approach. This sequence is 
located intracellularly, and it is involved in coupling to  Gi/o proteins, being responsible for CB1 receptor desensitisation and 
internalisation. Developed molecularly imprinted materials were found to be in the nanometre scale, with a particle size of 
126.4 ± 10.5 nm at pH 3 (25 ºC) and spherical shape. It was also observed that the size was sensible to temperature changes 
being reduced to 106.3 ± 15.2 nm at 35 °C. Lower critical solution temperature of this polymer was found to be ≈ 33.4 °C. 
The affinity and selectivity of the artificial antibody were assessed through dot blot and Western blot experiments. For the 
latter, recombinant fusion proteins GST-CB1414-472 and GST-CB1414-442 were produced to work respectively as target and 
negative control proteins. The control protein did not carry the target epitope for being devoid of last 30 amino acids at the 
C-terminus. The results demonstrated that the anti-CB1 material recognised selectively the target protein, thanks to the 
presence of the 15-amino acid sequence selected as epitope, which revealed that binding occurred at the C-terminus of the 
receptor itself. The methodology presented may pave the way for the development of novel imprinted nanomaterials for other 
proteins included in the superfamily of the G-protein-coupled receptors (GPCR).
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Introduction
Developing artificial materials having antibody-like molecu-
lar recognition ability has experienced a fast expansion over 
the last decade. For this purpose, researchers have empha-
sised on imprinting macromolecules on synthetic polymers 
as a way to yield artificial antibody analogues [1]. Molecu-
larly imprinted polymers (MIP), sometimes referred to as 
plastic antibodies, are materials most often developed by 
copolymerisation of vinyl and/or acrylic type of functional 
and cross-linking monomers in the presence of a template 
[2]. Traditionally, these materials were synthesised by free 
radical polymerisation (FRP) in bulk format [3]. However, 
bulk MIPs usually present a high number of non-specific 
sites, which contribute to cross-reactivity and thus limit their 
application in clinical diagnostics, drug delivery, chemi-
cal sensing, or separation techniques [4]. As an effort to 
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overcome the aforementioned drawbacks, controlled or liv-
ing radical polymerisation (CRP) strategies have been com-
bined with imprinting technology achieving improved rec-
ognition properties. CRP allows for the control over polymer 
architecture, providing an improved inner morphology due 
to a more homogeneous distribution of cross-linking points 
[5]. Hence, obtained MIPs resemble more to monoclonal 
antibodies, showing (pseudo)monoclonal binding behaviour 
with less cross-reactivity [3].
Many of these challenges have also been addressed, 
thanks to the relatively recent emergence of nano-sized 
MIPs [6], which have been fabricated using different strate-
gies, including the recently emerged solid-phase synthesis 
[7–10]. Unlike other strategies, it relies on having the tem-
plate covalently immobilised on a solid support, instead of 
having it free in solution. Immobilised templates present 
reduced number of degrees of freedom to establish mon-
omer-template complexes, thereby increasing the quality 
of the imprinting event [11]. This strategy may be adapted 
for oriented coupling of peptides or proteins, making all 
binding sites have the same orientation [12]. Accordingly, 
created binding sites will hence recognise the same amino 
acid sequence (epitope) of the template, and this will also 
contribute to MIP monoclonality [13].
The versatility of solid-phase synthesis has been empiri-
cally demonstrated both for templates having low molecular 
weight [7, 14] and macromolecules (> 1500 Da) [12, 15, 16]. 
However, for macromolecular templates, especially proteins, 
imprinting is still a challenge due to size restrictions, the 
poor stability at non-physiological environments [15], and 
the large number of functionalities, which may contribute 
to the creation of multiple types of binding sites with dif-
ferent affinities and specificities [4]. In order to circumvent 
these problems, different scientists considered imprinting 
a small exposed fragment of a larger molecule instead of 
imprinting the whole protein itself [17, 18]. The proposed 
strategy was called the epitope approach, and it imitates the 
binding behaviour of natural antibodies, which recognise a 
certain sequence of their target, namely, an epitope. Epitope 
imprinting has attracted much attention in bioanalysis, ther-
apy, and imaging as an alternative to natural antibodies [19, 
20]. Most often, linear peptide fragments that consist of 
6–12 amino acids are the predominant ones for imprinting 
[4, 21, 22]; however, longer peptides [23] or even nonlinear 
conformational epitopes, which are present in folded pro-
teins or fragments, have also been employed [19].
Considering potential benefits provided by epitope 
imprinting at nanoscale level, molecularly imprinted nano-
particles (MIN) as anti-CB1 artificial antibodies have been 
produced here, which bind specifically to the C-terminus 
of the CB1 receptor of the endocannabinoid system. The 
presence of the CB1 receptor in the central nervous sys-
tem (CNS) [24] explains many pharmacological effects 
associated to delta-9-tetrahydrocannabinol (THC), the 
main active substance of the plant Cannabis sativa, and the 
pathological regulation of its expression has been involved 
in a series of psychiatric (addiction, depression and anxiety) 
[25] and neurologic disorders (epilepsy, multiple sclerosis, 
and neuropathic pain) [26]. All these are very relevant due 
to their high prevalence and the lack of efficient pharma-
cological treatments. CB1 receptor presents a structure 
defined by an array of seven membrane-spanning helices 
with intervening intracellular loops and a C-terminal domain 
that can associate with G proteins [27]. The intracellular 
region is crucial to determine receptor functionality with 
regard to its coupling with  Gi/o proteins and its activation, 
receptor desensitisation, and internalisation [28]. Accord-
ingly, an epitope that corresponds to the C-terminal tail of 
the receptor positioned intracellularly has been selected as 
target for this work, having a sequence of 15 amino acids 
(458-KVTMSVSTDTSAEAL-472) located outside the α-H9 
helix. This epitope will serve as template for the synthesis 
of MIPs at nanoscale level that will be exploited as antibody 
substitutes for the study of the CB1 receptor, which will 
allow for the determination of its expression and regulation 
in a wide variety of disorders. Especially considering the 
limited specificity and reproducibility presented so far by 
natural antibodies employed in this context [29].
Experimental
Materials and apparatus
Target peptide (purity 96.76%, Maldi-TOF (m/z): (M +  H+) 
1643.57) containing an additional cysteine residue 
(C-KVTMSVSTDTSAEAL) (Fig. 1) was custom-synthe-
sised by Caslo ApS (Denmark). As control peptide (purity 
98.38%, Maldi-TOF (m/z): (M +  H+) 1717.26) a 15-amino 
acid sequence also containing an additional cysteine was 
used  (C-HRAAESCIKSTVKIA). This sequence can be 
found at the intracellular helix 9 motif of the CB1 receptor 
[28]. Both peptides were analysed using the software Agadir 
(http:// agadir. crg. es/) in order to estimate their propensity to 
create α-helixes in aqueous solutions. Accordingly, it was 
observed that, at pH, temperature and ionic strength val-
ues used at this work, theoretical peptide tendency to create 
α-helixes was always below 1%, which denotes that selected 
epitopes will be in linear state at all working conditions.
For peptide immobilisation, glass beads with a diameter 
of 150–212 µm were acquired from Merck (Madrid, Spain). 
Succinimidyl iodoacetate (SIA) (> 97%) was purchased from 
Thermo Fisher Scientific (Spain), and cysteamine hydro-
chloride (> 98%) was acquired from Merck (Spain).
The silanes 3-aminopropyltriethoxysilane (APTES) 
(99%) and 1,2-bis(triethoxysilyl)ethane (BTESE) (95%), 
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and the monomers N-isopropylacrylamide (NIPAm) (97%), 
N-tert-butylacrylamide (TBAm) (97%), acrylic acid (AA) 
(99%), N-(3-aminopropyl) methacrylamide hydrochlo-
ride (APMA) (98%), and N,N’-methylenebis(acrylamide) 
(BisAm) (99%) were obtained from Merck (Spain). The 
water-soluble photoiniferter diethylthiocarbamoylsulfanyl 
acetic acid (DCAA) was synthesised as described else-
where [30] using sodium diethyldithiocarbamate (98%) 
and sodium chloroacetate (98%) acquired from Alfa-Aesar 
(Spain) (yield 51.3%). High-resolution mass spectra for 
the iniferter having a chemical formula  C7H13NO2S2 were 
obtained by positive-ion electrospray ionisation (ESI-
QTOF-MS). m/z, (M + H) + 208.0464; calculated mass, 
207.0388; found mass, 207.0388; difference, 0.34 ppm.
Synthesised nanoparticles were biotinylated using 
( +)-biotin N-hydroxysuccinimide ester (biotin-NHS) 
(98%) purchased from Merck (Spain).
Fig. 1  Schematic representation of the entire protocol employed to synthesise biotinylated molecularly imprinted nanoparticles
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Fatty acid free bovine serum albumin (BSA) (99%), 
used for blotting experiments, was purchased from Merck 
(Spain) while Tween-20 was acquired from Alfa Aesar 
(Spain).
HPLC-grade ethanol (EtOH) and acetonitrile (ACN) 
and reagent-grade acetone and methanol were purchased 
from Scharlab (Spain), whereas dimethyl sulfoxide was 
acquired from Panreac (Spain). Buffer solutions were pre-
pared with ultrapure water (resistivity of 18.2 MΩ.cm), 
which was obtained using Elix20 reverse osmosis and 
Milli-Q water purification systems from Merck (Spain). 
All other reagents were analytical grade and they were 
used as received.
The Apparatus section has been moved to Supplementary 
information.
Immobilisation of the target peptide 
on the solid‑phase
Figure 1 depicts schematically the immobilisation protocol 
for the target peptide. First, 120 g of glass beads (GB) were 
activated in a boiling solution of NaOH 4 M for 30 min. 
Next, the beads were washed with water and methanol and 
dried in an oven at 100 °C. Activated GB were immersed 
in a 100 mL 95:5 ethanol:water solution acidified with 
1 mL acetic acid and then heated up to 70 °C. Immediately 
after, 3 mL APTES and 0.5 mL BTESE were added (10:1 
APTES:BTESE molar ratio) and it was left to react over-
night at RT. Thereafter, silanised GB were filtered, washed 
with methanol and acetone, and then dried in a desiccator 
under vacuum. Finally, for complete water removal, they 
were placed in an oven at 150 °C for 1 h. To determine 
the grafting degree of APTES, the ninhydrin test was per-
formed as detailed by the manufacturer; to this end, 1 mg 
of silanised GB and 2% ninhydrin solution were used from 
Merck (Spain), which resulted in a grafting degree of 
544 ± 66 µg APTES per g of GB.
Thirty grams of dry GB bearing  NH2 groups were incu-
bated for 2 h in 25 mL of a 1 mg/mL solution of SIA, pre-
pared in 0.1 M phosphate buffered saline containing 0.1 M 
NaCl at pH 7.4 (PBS). Then, the beads were filtered, washed 
thoroughly with water and acetonitrile, and immersed in a 
25 mL solution of 10 mM sodium borate and 5 mM EDTA 
(pH 8.3), which contained 10 mg of the target peptide. After 
overnight reaction at 4 °C, the GB were filtered, washed 
repeatedly with 0.1 M PBS and water, and immersed in 
25 mM phosphate buffer at pH 7.4 (PB) to proceed with the 
solid-phase synthesis. The amount of peptide bound to the 
solid support was estimated using the Pierce BCA protein 
assay kit (Fisher Scientific, Spain), using a sample of 1 g 
of peptide-bound GB. As a result 51.5 ± 7.3 µg of bound 
peptide per g of GB was observed.
Solid‑phase synthesis of imprinted nanoparticles
For molecularly imprinted nanoparticle (MIN) synthesis, 
72.7 mg of NIPAm (0.623 mmol, 43.75% over total moles 
of functional monomers), 70 mg of TBAm (0.534 mmol; 
37.5%), 32.1  mg of APMA (0.178  mmol; 12.5%), 6 
µL of AA (0.089 mmol; 6.25%), and 11.5 mg of BisAm 
(0.075 mmol) as cross-linker were added to 25 mL of PB, 
containing 30 mg of peptide-bound GB. A total monomer 
amount of 1.5 mmol was used, 5% of which were relative 
to the cross-linker. This mixture was adapted from [31] 
and [32] taking into consideration the percentage of acidic, 
basic, hydrophobic, and hydrophilic amino acids present in 
the target peptide. To avoid monomer loss due to volatilisa-
tion, the solvent (PB buffer) was initially purged with  N2 for 
30 min in a round bottom glass tube sealed with a rubber 
septum. Then, all monomers were added and the mixture 
was degassed for another 5 min while being in an ice bath. 
After this, 11 mg of the water-soluble iniferter (DCAA) 
were added (3.5% of total monomer moles) and the tube was 
placed horizontally between two UV lamps to proceed with 
the polymerisation, irradiating the mixture from the top and 
the bottom for 30 min. Within the first 15 min, the mixture 
was placed in an ice bath during irradiation, whereas the last 
15 min was conducted at RT.
After polymerisation, the GB were transferred to a 
60-mL solid-phase extraction cartridge fitted with a poly-
ethylene frit (20-µm porosity) from Merck (Spain) to per-
form a temperature-based affinity separation of synthesised 
MIN [9]. Initially, a warm washing step was carried out to 
remove low-affinity MIN, small oligomers, and unreacted 
compounds. To this end, the cartridge was preconditioned 
at 40 °C using a water bath and, thereafter, 10 × 20 mL of 
ultrapure water at 40 °C was percolated through it using a 
Vac Elut vacuum manifold (Agilent Technologies, Spain). 
Twenty millilitres corresponds approximately to the bed vol-
ume. After this step, high-affinity MIN will stay bound to the 
solid phase, whereas reagents used for polymerisation will 
be removed. At this point, biotinylation of MIN was per-
formed in order for the particles to be usable in subsequent 
Western blot and dot blot experiments. To this end, 5 mg of 
biotin-NHS was dissolved in 1 mL of DMSO and 100 µL of 
this solution was added to 25 mL PB solution. This mixture 
was immediately added to the SPE cartridge containing the 
MIN bound to the GB, and it was left to react for 2 h in the 
dark. Afterwards, unreacted biotin was removed percolating 
5 × 20 mL of ultrapure water through the cartridge at RT.
Elution of biotinylated MIN from the solid support was 
performed through cold washings at 6 °C. To this end, the 
cartridge was preconditioned in an ice bath and, thereaf-
ter, 8 × 20 mL of borate buffer 50 mM at 6 °C adjusted to 
pH 9.5 was percolated, reaching a final volume of MIN 
suspension of 160 mL. This was concentrated down using 
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a rotatory evaporator obtaining a concentrated solution 
of about 30 mL of MIN, which was extensively dialysed 
through 6000–8000 KDa membranes (Spectrum Chemical, 
USA) in ultrapure water to remove salts. Then, it was fur-
ther concentrated using an Amicon Ultra-15 centrifugal filter 
and washed repeatedly with ultrapure water, which served 
for further removing any remaining unreacted compound or 
salt. Finally, the nanoMIP suspension (around 2 mL) was 
transferred to a tube and water was evaporated to dryness 
using a sample concentrator DB200/3 from Techne (UK). 
The solid residue was weighed using a high-resolution 
ME215 balance from Sartorius (Spain) with a precision of 
0.01 mg. Each synthesis produced 10.25 ± 0.81 mg of poly-
mer (0.34 ± 0.03 mg.g−1 of GB) which is in accordance with 
other works [31, 32]. After weigh determination, solid MIN 
were resuspended in 10 mL of formate buffer 25 mM at pH 
4 to maintain colloidal stability.
Column packing and HPLC experiments
Different stationary phases were prepared for liquid chro-
matography experiments. The main one, used as target, con-
sisted of GB having the target peptide grafted on its surface 
(the grafting protocol is detailed in the “Experimental” sec-
tion), while the others, used as control or blank stationary 
phases, were respectively made of the control peptide or 
cysteamine grafted to the beads. Cysteamine was used to 
couple to pendant SIA units giving rise to a blank column 
having no peptide attached. The used protocol to attach 
either the control peptide or cysteamine onto functionalised 
GB was the same as the one used for the target peptide.
Three grams of GB having the target peptide, control pep-
tide, or cysteamine immobilised on its surface were indi-
vidually packed in stainless columns of 150 mm in length 
and 4.6 mm in diameter. The packing was performed using 
the Pack in a Box column packing system from Restek 
(USA) comprised of a dual piston pump and a 20-mL res-
ervoir using water as the pushing solvent. Column pack-
ing was started at 1 mL  min−1 and gradually increased to 
20 mL   min−1 until constant pressure was observed for, 
at least, 10 min. Then, it was reduced to 1 mL  min−1 for 
another 5 min. HPLC experiments were carried at a flow rate 
of 0.4 mL  min−1, using a liquid chromatograph coupled to 
a fluorescence detector working at 242 nm and 518 nm as 
excitation and emission wavelengths, respectively. Injection 
volume was 20 µL for all experiments. Column thermostat 
was set to the desired temperature and it was left to stabilise 
for 30 min prior to nanoparticle injections.
Dot blot and Western blot experiments
MIN-peptide binding was assessed by dot blot experiments 
using nitrocellulose membranes. Spots of 1 µL having known 
concentrations of the target and control peptides were blot-
ted on the membrane and it was left to dry. Thereafter, non-
specific sites were blocked using 0.5% BSA in 0.1 M PBS (pH 
7.4) for 1 h at RT; afterwards, the membranes were incubated 
in a 1:5000 diluted stock suspension of 510 mg  mL−1 of MIN 
at 35 ºC in 0.1 M PBS for 2.5 h. Finally, they were washed 
for 10 min in 0.1 M PBS containing 0.2% Tween 20 (PBS-T) 
three times. All these steps were performed under constant 
circular shaking.
Binding of biotinylated MIN to the peptide on nitrocellu-
lose membranes was quantified by chemiluminescence. For 
this purpose, the commercial Vectastain ABC-HRP Kit was 
used (Vector laboratories, UK), which contains avidin (Rea-
gent A) and biotinylated horseradish peroxidase (HRP) (Rea-
gent B). Ten microliters of reagent A of the kit and another 
10 µL of reagent B were added to 10 mL of PBS-T and it 
was left to react for 1 h. Then, the nitrocellulose membranes 
were immersed into the mixture and they were left to react 
with the avidin–biotin/HRP complex for 1 h. Thereafter, they 
were washed three times with PBS-T and then with PBS. 
Finally, for image acquisition, an Image Quant 350 imager 
was used, which was acquired from GE Life Sciences (Spain). 
Dots were visualized using the Clarity Western ECL Sub-
strate from Bio-Rad (Spain) according to the manufacturer’s 
recommendations.
For Western blot experiments recombinant fusion pro-
teins, GST-CB1414-472 and GST-CB1414-442, were produced as 
described in supporting information. An equimolar mixture of 
3.6 pmol µL−1 of each protein was prepared as stock solution, 
and it was further diluted using urea 4 × buffer (supplementary 
information). Achieved final concentrations of recombinant 
proteins were 0.075, 0.15, 0.30, 0.60, 1.2, 1.8, and 3.6 pmol 
µL−1. Once they were denaturalised, 10 µL of each dilution 
was loaded on the gel and electrophoresis was run at 120 V in 
a Protean II xi cell from Bio-Rad (Spain). After migration, pro-
teins were transferred to Immun-Blot PVDF membranes using 
a Trans-Blot transfer system (Bio-Rad, Spain) applying 30 V 
for 18 h. Thereafter, the membranes were gently washed with 
ultrapure water and immersed in an aqueous solution contain-
ing 7% acetic acid and 10% methanol for protein fixation. The 
membranes were incubated in this solution for 15 min at RT 
under gentle shaking and, afterwards, they were washed with 
ultrapure water for 10 min at RT, and another two times using 
PBS-T. At this point, the membranes were ready for being 
blocked and incubated with the MIN suspension as detailed 
above for dot blot experiments.
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Results and discussion
Assessment of the solid‑phase synthesis protocol 
using liquid chromatography
Liquid chromatography was considered as a tool to deter-
mine the best conditions at which MIN-peptide binding 
occurred on the surface of GB. It was hypothesised that, 
after peptide attachment to GB (Experimental section), 
these beads could be packed inside an HPLC column and 
use them as stationary phase. In this context, if a suspen-
sion of MIN passes across the column, part of those nano-
particles will be trapped due to peptide-MIN interactions, 
while non-bound particles will elute and quantified in the 
fluorescence detector. For that purpose, synthesised MIN 
were provided with fluorescence using N-fluoresceinyl 
acrylamide (supplementary information). All these chro-
matographic experiments were used to assess MIN binding 
to the target peptide and were found to be helpful to deter-
mine the best conditions to carry out solid-phase synthesis 
and subsequent affinity-based washes.
First, temperature effect on MIN binding was studied. 
For this purpose, target peptide, control peptide, and the 
blank column (containing cysteamine) (supplementary 
information) were preheated at different temperatures. 
Then, the suspension of fluorescent MIN nanoparticles 
was injected, and unbound MIN quantified, which passed 
through the column and gave rise to a chromatographic 
peak. Figure 2a depicts peak area values corresponding 
to unbound MIN at different temperatures. As it can be 
observed, minimum peak area is registered at 30–40 °C 
for all stationary phases, which means stronger binding, 
that is, less elution. At lower or higher temperatures, MIN 
elution increases, especially with stationary phases con-
taining the control peptide or cysteamine. Below 30 °C, 
MIN binds almost equally to the target peptide or the 
control one; this might suggest that, at this point, reten-
tion is manly governed by non-specific interactions. In 
contrast, above 30 °C, retention at the column containing 
the target peptide is significantly higher, which demon-
strates that created binding sites are responsible for MIN-
peptide binding. These experiments clearly demonstrate 
temperature-based behaviour of created MIN, which is 
definitely in agreement with other works, suggesting that 
the imprinted material presents thermoresponsive char-
acter [17]. In this context, temperatures below the lower 
critical solution temperature (LCST) contribute to particle 
swelling, as they turn more hydrophilic. Consequently, the 
size of binding sites increases and, therefore, a selectivity 
Fig. 2  Peak areas relative to unbound fluorescent MIN using a water, b ethanol, c 25 mM PB (pH:7.4), and d 0.1 M PBS (pH:7.4) as mobile 
phases
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loss may occur. This may explain the reason why both the 
target and control peptides show similar binding below 
30 °C. Comparatively, the blank column shows poorer 
retention than peptide-bound stationary phases, which 
denotes that binding is happening, thanks to the presence 
of the peptide on GB, discarding other possibilities like 
possible physisorption on glass or binding to free amino 
groups provided by the APTES layer. Based on all these 
findings, it was deduced that, for affinity-based washes, 
40 °C could be a good temperature to keep retained MIN 
particles having highest affinity, while removing unreacted 
compounds.
Alternatively, ethanol was tested as mobile phase in 
order to assess MIN-peptide interactions in a non-aqueous 
medium. Hydrophobic binding should be minimised using 
ethanol as medium, and, therefore, another binding behav-
iour might be expected. As it can be deduced from Fig. 2b, 
the “U”-shaped graphs appreciable at Fig. 2a are not pre-
sent in Fig. 2b. In the latter, stronger binding of MIN to 
all tested stationary phases can be observed at temperatures 
below 30 °C. In fact, maximum retention was observed at 
4 °C rather than at 40 °C (Fig. 2b). When using ethanol, the 
hydrophilic/hydrophobic shift of MIN was not found to be 
determinant in the binding event, as opposed to water. It 
was also observed that low temperatures caused weak non-
specific binding, which could be disrupted above 30 °C. 
Specific retention (interpreted as peak area ratios between 
control peptide/target peptide or blank column/target pep-
tide) was maximised at 50 °C and 60 °C. Making a com-
parison between water and ethanol as mobile phases, it was 
observed that, at 50 °C, the control peptide/target peptide 
signal ratio was 5.37 using water and 1.93 using ethanol, 
whereas blank column/target peptide ratios were 3.96 and 
1.79, respectively. It could be assumed that the higher the 
ratio, the more specific the interaction; therefore, it was 
found that water was providing better binding than ethanol.
All data shown in Fig. 2a were obtained using ultrapure 
water as mobile phase. However, in order to determine 
the influence of salt concentration of MIN-peptide bind-
ing, chromatographic experiments were performed using 
25 mM PB and 0.1 M PBS at pH 7.4 as mobile phases. 
Results are shown in Fig. 2c and d. In both figures, higher 
binding is observed as temperature increases above 30 °C; 
however, a little difference can be appreciated when Fig. 2c 
and d are compared. At temperatures above the LCST MIN 
will turn hydrophobic, and, as a result, non-specific bind-
ing may be increased. This binding is stronger as salt con-
centration increases, probably due to the salting out effect, 
and that is why 25 mM PB buffer as mobile phase (Fig. 2c) 
provides higher peak areas than 0.1 M PBS (Fig. 2d), which 
shows almost full retention. Conversely, below 30 °C, MIN 
are more hydrophilic, and salt concentration contributes 
negatively to binding. Comparing results recorded using 
ultrapure water, 0.1  M PBS and 25  mM  PB as mobile 
phases, the signal increase observed above 40 °C using water 
is not appreciable with the other mobile phases. Probably, 
the presence of phosphate salts or even NaCl are making 
hydrophobic interactions stronger, resulting in no binding 
difference between tested stationary phases (Fig. 2c and d).
It was also desirable to know which conditions could 
maximise MIN recovery at affinity-based washes after 
solid-phase synthesis. With this purpose, MIN-target peptide 
binding was examined at different mobile phases. Elution of 
MIN particles was measured at different pH and tempera-
tures, obtaining the results illustrated in Fig. S1. MIN-pep-
tide binding was maximum at pH below 5, whereas particle 
elution happened preferably at high pH. Moreover, like in 
previous experiments, decreasing the temperature favoured 
MIN elution. Based on this, a buffer having basic pH and 
low temperature could be recommendable to collect MIN 
particles after solid-phase synthesis.
Characterisation of imprinted nanoparticles
It is well-known that hydrogels prepared with monomers 
such as NIPAm [33] or even TBAm [34] can undergo a 
reversible volume phase transition and they can swell in a 
solvent at low temperatures, whereas they shrink if the tem-
perature is increased over the LCST. Below this temperature, 
polyNIPAm (LCST ≈ 32 °C) is water soluble [35], whereas 
above it, the polymer turns insoluble and it aggregates. 
Phase behaviour of the MIN was determined through tur-
bidity experiments as detailed elsewhere [33]. As depicted 
in Fig. S2, absorbance changes with temperature confirm 
phase transition of MIN, thereby demonstrating the ther-
moresponsive character of the polymer. Based on presented 
results, LCST, defined at 10% absorbance [33], was found 
to be 33.4 ºC.
Size analysis of imprinted nanoparticles was determined 
through dynamic light scattering analysis (DLS) using dif-
ferent pH and temperatures. To this end, MIN were sus-
pended in 25 mM formate (at pH:3 and pH:4), 25 mM 
acetate (pH:5), 25 mM phosphate (pH:6, pH:7 and pH:8), 
and 25 mM carbonate buffers (pH:9 and pH:10). Particle 
size and polydispersity indexes were determined at all those 
pH, setting different temperatures, one of them below the 
LCST and the other one above. According to results pre-
sented in Fig. 3a, at most of tested pH values, no remark-
able particle size difference was detected by DLS, except 
for pH 6, 7, and 8. At these values, the size was larger at 
40 °C than at 30 °C, especially at pH 8. This may happen 
due to particle aggregation because of poor stability of the 
colloidal suspension. This aggregation is more evident at 
40 °C, when particles have switched from a hydrophilic 
to a hydrophobic state. At this point, their water solubility 
decreases and, thereupon, they form aggregates. Figure 3b 
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shows particle size difference using the same MIN suspen-
sion at two tested temperatures. Measurements performed 
at 40 °C were less reproducible due to particle aggregation, 
and relatively long sonication times were required between 
measurements to achieve good-quality signals. To determine 
how pH influenced particle aggregation, size analysis was 
performed at pH 3 and 7 at temperatures comprised between 
25 and 55 °C (Fig. 3c). Due to the thermoresponsive nature 
of MIN, increasing temperature should give rise to smaller 
particles; however, the opposite happened above 40 °C for 
MIN suspended in PB (pH:7), which confirmed aggregation 
phenomena at neutral pH. Nevertheless, compared to pH 7, 
particle size was not so influenced by temperature at pH 3, 
which confirmed higher stability of MIN at this pH. Between 
25 and 35 °C, no aggregation was perceived and, due to 
particle shrinking, a decrease in size from 164.0 ± 28.2 nm 
(PDI: 0.84 ± 0.02) to 129.0 ± 15.2 nm (PDI: 0.16 ± 0.03) was 
observed at pH 7 (Fig. 3d), while at pH 3, it decreased from 
126.4 ± 10.5 (PDI: 0.79 ± 0.22) to 106.3 ± 15.2 nm (PDI: 
0.32 ± 0.04).
Particle aggregation may be attributed to weak repul-
sive forces between them, which may be related to a net 
effective surface charge close to neutrality. Normally, col-
loidal suspensions having a zeta-potential above 30 mV or 
below − 30 mV are considered moderately stable against 
aggregation because repulsive forces are high enough to pre-
vent it [36]. Taking this into consideration, the zeta-potential 
of MIN suspensions was measured, which were prepared 
at different pH, as previously detailed for size analysis. As 
it can be observed in Fig. 4a, the isoelectric point of MIN 
is about 6.5, while the highest suspension stability will 
be reached at pH 3, where zeta-potential was found to be 
25.22 ± 3.52 mV, or even at pH 10 (− 20.68 ± 1.55 mV). At 
pH 3, particle charge may be expected to be positive, since 
carboxylic groups coming from the monomer AA will be 
non-ionised, while amino groups of APMA will be posi-
tive. Instead, just the opposite may be expected at pH 10. 
TEM micrographs depicted in Fig. 4b show the spherical 
morphology of developed MIN nanoparticles having a size 
in the nanometre scale.
Dot blot and Western blot experiments
In order to determine the best conditions for blotting assays, 
a series of dot blot experiments were carried out. Initially, 
the concentration of MIN that provided the highest signal 
with lowest background noise was determined. For this pur-
pose, increasing amounts of the target peptide were spotted 
Fig. 3  Particle size of imprinted nanoparticles measured a at pH val-
ues comprised between 3 and 10 at two different temperatures and 
c at temperatures comprised between 25 and 55 at two different pH. 
Particle size distribution data (n = 3) measured at b pH 7 (30 °C and 
40 °C), and d pH 3 (25 °C and 35 °C)
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on a series of nitrocellulose membranes; then, they were 
blocked using 0.5% or 5% BSA; and, finally, they were 
incubated at RT in different dilutions of a stock solution of 
510 mg  L−1 of MIN. As it can be observed in Fig. 5a, a 1:100 
dilution was not enough to properly differentiate signal from 
the background, while diluting MIN 1:10,000 provided too 
low sensitivity. Thus, dilutions that ranged from 1:1000 to 
1:5000 may be suitable. In addition, it was observed that 
results were quite similar regardless the percentage of BSA, 
besides 5% BSA provided higher background noise than 
0.5%. Further experiments were also carried out reducing 
even more than 0.5% the BSA level; however, the signal to 
noise ratio did not improve compared to 0.5%, thereby estab-
lishing this value as pertinent. Finally, temperature effect on 
MIN binding was also assessed. Figure S3 illustrates optical 
densities measured for each spotted amount of peptide after 
incubating the membranes in MIN suspensions at different 
temperatures. As shown in the figure, incubation at 35 °C 
Fig. 4  a Zeta-potential values 
recorded for a 0.1 mg  mL−1 
MIN suspension at different 
pH. b TEM images at different 
magnifications of developed 
imprinted nanoparticles
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provides the highest sensitivity, which matches with the 
thermoresponsive character of developed MIN.
At optimised conditions, another dot blot experiment was 
run using membranes having blots with different amounts of 
the target peptide and the peptide used as control (Fig. 5b). 
Chemiluminescence signal was dependant on the spotted 
amount of peptide on the membrane obtaining a saturation 
like behaviour. For comparison, the control peptide was also 
spotted in the same membrane; however, the obtained signal 
was negligible in comparison with the target.
The dot blot assay was also used as a tool to assess affin-
ity of developed MIN. To this end, it was necessary to first 
determine the chemiluminescent specific activity of MIN, 
which may be expressed as optical density (OD) increment 
as a function of MIN amount on the membrane. This was 
carried out spotting increasing amounts of biotinylated nan-
oparticles (0.1 ng to 50 ng) on nitrocellulose membranes 
and, then, allowing them to dry at 40 °C for proper fixation. 
Finally, membranes were left to react with the avidin–biotin/
HRP complex and chemiluminescence signal was acquired 
as detailed in the “Experimental” section. Signal depend-
ence to the amount of MIN on the membrane showed two 
linear regions with different slopes. The first one, between 
0.1 and 1 ng of MIN, presented a slope or specific activity 
of 952 OD  ng−1, whereas the second, between 1 and 25 ng, 
revealed a specific activity of 373 OD  ng−1. After knowing 
this, another dot blot assay was performed spotting increas-
ing peptide amounts in a nitrocellulose membrane and incu-
bating them in a 0.1 µg  mL−1 solution of MIN. Figure 6a 
depicts obtained OD values versus the peptide amount fixed 
Fig. 5  a Results obtained from dot blot experiments using different 
dilutions of MIN after membrane blocking with 0.5% or 5% BSA. 
b Dot blot experiment carried out using a single membrane spotted 
with detailed amounts (µg) of the target and control peptides. The 
graph below depicts the optical densities corresponding to each spot
Fig. 6  a Optical densities recorded as a function of the spotted 
amount of peptide after membrane incubation in a 0.1 µg  mL−1 sus-
pension of MIN at 35 °C for 24 h. b Equivalent amount of MIN (ng) 
bound to each peptide spot having the illustrated nmoles
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on the membranes; instead, Fig. 6b shows the equivalent 
amount of MIN bound to each peptide spot, which was cal-
culated using mentioned specific activity data. The experi-
mental data depicted in Fig. 6b was adjusted to a one-site 
binding hyperbola using the GraphPad 9.0 software using 
the following expression:
where B and F represent bound and free concentrations of 
a ligand, Bmax is the maximum specific binding, and  KD is 
the equilibrium dissociation constant. This model has been 
adapted to the particular situation of the present work, where 
binding experiments have been conducted on a nitrocellu-
lose membrane rather than in solution. Fitting parameters 
revealed an apparent Bmax value of 34.29 ± 4.14 ng of 
equivalent MIN, which may give an idea about the maxi-
mum amount of MIN capable of being bound to the peptide. 
Making the assumption that 34.29 ng of equivalent MIN 
will bind to the maximum peptide amount used in the assay, 
i.e. 10 nmol of peptide, the estimated number of sites could 
be expressed as 0.29 nmol of peptide per ng of equivalent 
MIN.  KD value obtained from data fitting was found to be 
2.15 ± 0.70 nmol of peptide. This should not be understood 
as a real dissociation constant, but rather a way to make an 
approximation to material affinity for comparative purposes.
In order to better assess the specificity and sensitiv-
ity of developed anti-CB1 MIN generated against the 
carboxy-terminus of the CB1 receptor (458-KVTMSVS-








used as target for Western blot assays. To this end, the 
sequence of amino acids 414 to 472 was fused to the pro-
tein GST (glutathione S-transferase). As negative control, 
the fusion protein GST-CB1414-442 was employed, which 
did not have the C-terminus sequence (458–472) of the 
CB1 receptor. Figure 7a shows the sequences of fabri-
cated fusion proteins as well as the results obtained from 
their purity analysis. It can be corroborated that molecular 
masses obtained empirically were the expected ones for 
produced proteins. Figure 7b depicts representative data 
relative to a Western blot assay using developed MIN. 
An intense chemiluminescence signal can be observed in 
Fig. 7b which shows linear dependence to the concentra-
tion of GST-CB1414-472 loaded per lane. Conversely, lanes 
loaded with GST-CB1414-442 presented almost negligible 
signals, since this protein did not carry the target epitope 
for being devoid of last 30 amino acids at the C-terminus. 
The signal (optical density) provided by MIN was linear 
between 0.75 and 18 pmol at both tested temperatures; 
however, sensitivity was remarkably higher at 35 °C. The 
detection limit (explained as the cut-off point of the curves 
with the abscissa axis) was found to be 1.6 and 0.67 pmol 
at 20 °C and 35 °C, respectively. Based on these findings, 
we can confirm that solid-phase imprinting of peptides has 
proven useful to develop MINs that behave as natural anti-
bodies against the C-terminus of the CB1 receptor. Nev-
ertheless, efforts are still necessary to improve this recent 
methodology to produce high-affinity MIN with higher 
yields. Developed MIN nanoparticles have been validated 
in assay analogues to which commonly are used for natural 
Fig. 7  a Purity and molecular weight analysis of recombinant GST-
CB1414-472 and GST-CB1414-442 fusion proteins using SDS–poly-
acrylamide gels. b Results of a Western blot assay of developed 
anti-CB1 artificial antibodies against increasing amounts of fusion 
proteins. The graph below represents the corresponding optical densi-
ties for each level of the target protein
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antibodies. Relying on the good results provided by this 
material, it may be further exploited in the near future 
for specific localisation and quantification of this receptor 
through bioimaging techniques in cells and tissues.
Conclusions
Artificial antibodies against the membrane receptor CB1 
have been developed in this work, having an epitope that 
binds selectively to the C-terminus extreme. So far, MIN-
based artificial antibodies have mainly focused on globular 
proteins; instead, the solid-phase imprinting of epitopes 
has exploited here as a proof of concept to develop MIN 
against linear sequences of membrane proteins. The devel-
oped imprinted material has proven efficient for binding the 
target protein through the intracellular region of the receptor 
(458-KVTMSVSTDTSAEAL-472) in Western blot experi-
ments. Control GST fusion proteins not having this sequence 
were unable to bind the plastic antibody, thereby demonstrat-
ing that the epitope-imprinting approach was a good choice 
to accomplish the pursued goals. The methodology followed 
in this work has served to fabricate high-quality antibodies 
that will be very likely applied in other bioanalytical tech-
niques. Potential benefits presented by the produced mate-
rial could be exploited for receptor isolation and purification 
from soluble extracts of this protein, working like antibodies 
in immunoprecipitation approaches. Additionally, they could 
even serve as recognition elements for protein separation in 
affinity chromatography, and they could also be appropri-
ate for bioimaging. All this will definitely help in obtaining 
valuable information concerning receptor localisation and 
distribution in biological tissues.
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